about
Vaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalLow frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.Neuropsychiatric features of a cohort of patients with systemic lupus erythematosusRegulatory T cells in microbial infection.Progressive Multifocal Leukoencephalopathy and Systemic Lupus Erythematosus: Focus on Etiology.Anti-N-Methyl-D-Aspartate Receptor Encephalitis in HIV InfectionUltrasound detects subclinical joint inflammation in the hands and wrists of patients with systemic lupus erythematosus without musculoskeletal symptoms.Immunodeficiency and autoimmunity coming together: a nearly missed diagnosis.Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.Erythema annulare centrifugum during rituximab treatment for autoimmune haemolytic anaemia.Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease.Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients.Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility.Fatal CTLA-4 heterozygosity with autoimmunity and recurrent infections: a de novo mutation.IL10 low-frequency variants in Behçet's disease patients.Erratum to "Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative"Cutting Edge: Intrathymic Differentiation of Adaptive Foxp3+ Regulatory T Cells upon Peripheral Proinflammatory ImmunizationHeterogeneous lupus-specific lesions and treatment outcome, in a single patient, over a period of timeCharacterization of damage in Portuguese lupus patientsComment on: PML in patients with systemic lupus erythematosus: a systematic literature reviewThe role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus[Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus]Comment on: Hydroxychloroquine-induced retinal toxicity in an asymptomatic patientParadoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumoniaClinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration InitiativeDyspnea in antiphospholipid syndrome: Beyond pulmonary embolismJuvenile dermatomyositis forty years on: Case reportLymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySAPHO: has the time come for tailored therapy?Mandibular resorption and vocal cord paralysis: a catastrophic form of systemic sclerosisHerpetic whitlow in the course of combined immunosuppressionChoroidal thickness changes in systemic lupus erythematosus patientsWhen systemic lupus erythematosus affects vision: a rare presentation of this conditionOcular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral centerMonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
P50
Q26749096-B1D2E865-D154-4BF7-A4D9-CD3AFC1D7DA0Q33403373-26697B8C-C39D-412E-BC7D-2A635292D35CQ33932451-4C89B8E3-A765-4E39-951D-68DEBAD33BF0Q36440223-BA04D480-48E0-473A-83AC-3AE73AB1E6EBQ36549731-840DDEFE-3542-4B43-AB19-DE18CA1A0E98Q36766244-153C51AA-B188-4B78-BCF2-4DC1562B8A40Q37562922-A3BCBBF9-E6DC-452B-9FB1-1AEC34A00DC9Q37598913-47ED91CF-FA93-4A41-96E4-592F24CF1AFEQ40114593-38EE28F0-4E79-4E71-84FD-75B140B57715Q43736626-E9DE7A90-CF2C-4A1D-9E9E-7163E1AAC86DQ44390686-DBFE1D96-1EA9-4B50-A5BE-D6BD1802C7DBQ46052910-32B234F1-2748-4EFB-BE6A-0C00DAA6D518Q46090296-2DBD9897-7B95-46B7-9872-790834F4C5DBQ46107042-EA93E371-C1CD-4BEC-94D4-6B663DAFB355Q47206614-C45E635F-9E4A-47EE-BFE9-998569A80E5AQ54214342-87E90AFF-4D9C-4122-94D9-90885826C1BCQ57489903-D8C1BA8B-2191-4D12-AA3A-25B9B6DBF7EEQ61053507-56C9D41E-1A2B-4F66-A835-604D97412F6DQ64060199-B15E4658-B0A7-4B20-B692-2C4C7E3869C8Q87080381-3A35DF62-CFD8-4BD6-A42E-EA7A41ED6861Q87683738-500180A1-F576-484B-B831-51FD733B830BQ88318585-32B57E64-E947-4F5B-B0A2-8E7305D35BB7Q88899471-50200D8E-C4E5-48AF-92D5-C08BA0AE9C95Q89338090-88DE2C61-DAEC-4F5F-94E7-A1208C85BA6EQ90286253-EF63DA28-D97E-4C85-BF7E-B0AD92F7A33EQ90314641-D2DAFDD9-35DB-4C4C-A0C4-8F8D871FC2C9Q90335282-048E533A-FBD6-49AD-B218-053AF1315DB5Q90670235-77B2C071-CFD5-4A76-884D-EB037EC04A68Q90762872-3FA4E6B2-40B5-4711-A272-C98CD376D30BQ91945497-2922E437-2AA8-4082-89D0-3185AC9C1877Q92059669-6D2EB532-E54E-4A3C-B1ED-26282BB693BAQ92178590-EF072831-263B-44B2-98A7-87147687812DQ92615780-BDCF1A23-60BE-4EFA-B550-83797EC0DF81Q92976353-44A68329-8097-420E-860B-1A52CCC3803BQ93008728-2837DACA-D6CF-49B5-B027-932A725BF5CFQ93382514-F255CB87-3D48-43B8-A6A8-8398A4880366
P50
description
researcher ORCID ID = 0000-0002-8917-6592
@en
wetenschapper
@nl
name
Maria F Moraes-Fontes
@ast
Maria F Moraes-Fontes
@en
Maria F Moraes-Fontes
@es
Maria F Moraes-Fontes
@nl
type
label
Maria F Moraes-Fontes
@ast
Maria F Moraes-Fontes
@en
Maria F Moraes-Fontes
@es
Maria F Moraes-Fontes
@nl
prefLabel
Maria F Moraes-Fontes
@ast
Maria F Moraes-Fontes
@en
Maria F Moraes-Fontes
@es
Maria F Moraes-Fontes
@nl
P214
P106
P1153
8267772800
P214
P31
P496
0000-0002-8917-6592